论文部分内容阅读
短暂性脑缺血发作(TIA)是缺血性脑血管病中较为常见的一种类型,约1/5—1/4的病人在初次起病后5年内发生脑梗塞、脑出血、蛛网膜下腔出血或心肌梗塞。有些病人则在TIA缓解2年后或更长时间才中风。TIA病人发生脑、心血管病的机会和远期死亡率都高于相应的一般人群,尤其TIA发作频繁的患者,近期发生动脉硬化性脑梗塞的机会更多,增加了患者致残和死亡的机会,因而是必需抓紧时机进行治疗的一种疾病。笔者近年尝试使用尿激酶治疗频繁TIA发作的患者,认为有一定疗效,现报道如下。
Transient ischemic attack (TIA) is a more common type of ischemic cerebrovascular disease and about 1 in 5 to 1 in 4 patients develop cerebral infarction, cerebral hemorrhage, and arachnoid Lower extremity hemorrhage or myocardial infarction. Some patients only stroke two years or more after TIA has been alleviated. TIA patients with brain and cardiovascular disease opportunities and long-term mortality were higher than the corresponding general population, especially in patients with frequent TIA attacks, the recent occurrence of arteriosclerosis more opportunities for cerebral infarction, increased patient disability and death Opportunity, therefore, is a disease that must be promptly treated. In recent years, I try to use urokinase in patients with frequent TIA attack, that there is a certain effect, are reported below.